First case report of renal improvement on tenofovir alafenamide in an HIV/hepatitis B virus-coinfected patient with adefovir-induced Fanconi's syndrome

AIDS. 2016 Jun 1;30(9):1487-8. doi: 10.1097/QAD.0000000000001059.

Authors

Magali Garcia¹, Gwenaël Le Moal, Cendrine Godet, Guillaume Beraud, Carine Chagneau-Derrode, France Roblot

Affiliation

¹ aLaboratoire de Virologie et Mycobactériologie, CHU de Poitiers bLITEC, EA4331, Université de Poitiers cService de Maladies Infectieuses, CHU de Poitiers, Poitiers, France dInteruniversity Institute of Biostatistics and Statistical Bioinformatics, Hasselt University, Hasselt, Belgium eEA2694, Université Lille 2, Lille fService de Gastroentérologie et Hépatologie, Polyclinique Bordeaux Rive Droite, Bordeaux gINSERM U1070, Poitiers, France.

PMID: 27167011
DOI: 10.1097/QAD.0000000000001059

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Absorptiometry, Photon
Adenine / adverse effects
Adenine / analogs & derivatives*
Adenine / therapeutic use
Alanine
Coinfection
Dose-Response Relationship, Drug
Fanconi Syndrome / chemically induced*
Fanconi Syndrome / diagnostic imaging
HIV Infections / drug therapy*
Hepatitis B, Chronic / drug therapy*
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Organophosphonates / adverse effects*
Tenofovir / analogs & derivatives
Treatment Outcome

Substances

Organophosphonates
adefovir
Tenofovir
tenofovir alafenamide
Adenine
Alanine